You may best recognise AFT Pharmaceuticals given that in its portfolio is one of Australia’s most recognisable OTC brands – that of Maxigesic, a general purpose painkiller including paracetamol and ibuprofen available on the shelves of pharmacies, and even AFT’s own e-channels on Amazon and elsewhere.
But the story of AFT Pharmaceuticals’ founder and CEO Hartley Atkinson is just as noteworthy.
In this episode of From the Wire, AFT Pharma’s founder and CEO Hartley Atkinson sits down with senior markets reporter Jonathon Davidson to discuss his roots in Perth, Western Australia; what it takes to start a pharmaceutical company from your garage; how the regulatory and commercial landscapes have changed in the last forty years, and, how emerging technologies like AI stand to further disrupt the industry.
This content is disseminated in partnership with AFT Pharmaceuticals Ltd. It is intended to inform investors and should not be taken as a recommendation or financial advice.
The material in this podcast is for information only and should not be treated as investment advice. Listeners are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions.
For HotCopper's full disclaimer, please click here.